TARS · Categories · Coverage
TARS - Analyst coverage initiated
Tarsus Pharmaceuticals Inc. (TARS) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for TARS
- Barclays initiated coverage on Tarsus Pharmaceuticals with a new price targetBarclays initiated coverage of Tarsus Pharmaceuticals with a rating of Overweight and set a new price target of $100.00
- Mizuho initiated coverage on Tarsus Pharmaceuticals with a new price targetMizuho initiated coverage of Tarsus Pharmaceuticals with a rating of Outperform and set a new price target of $100.00
- Goldman initiated coverage on Tarsus Pharmaceuticals with a new price targetGoldman initiated coverage of Tarsus Pharmaceuticals with a rating of Neutral and set a new price target of $19.00
- William Blair initiated coverage on Tarsus Pharmaceuticals with a new price targetWilliam Blair initiated coverage of Tarsus Pharmaceuticals with a rating of Outperform and set a new price target of $44.00
- Guggenheim initiated coverage on Tarsus PharmaceuticalsGuggenheim initiated coverage of Tarsus Pharmaceuticals with a rating of Buy
- Barclays initiated coverage on Tarsus Pharmaceuticals with a new price targetBarclays initiated coverage of Tarsus Pharmaceuticals with a rating of Overweight and set a new price target of $40.00
- HC Wainwright & Co. initiated coverage on Tarsus Pharmaceuticals with a new price targetHC Wainwright & Co. initiated coverage of Tarsus Pharmaceuticals with a rating of Buy and set a new price target of $40.00
- Oppenheimer initiated coverage on Tarsus Pharmaceuticals with a new price targetOppenheimer initiated coverage of Tarsus Pharmaceuticals with a rating of Outperform and set a new price target of $55.00